溶栓药物治疗游离皮瓣挽救的系统综述
该系统综述检索 Medline、Embase 和 PubMed 1987 年 1 月至 2019 年 1 月的文献,评估溶栓药物对微血管皮瓣挽救率的作用。现有证据级别低,尚无某一溶栓药显示更优的挽救效果,提示需前瞻性随机研究明确适应证、剂量、给药方式、疗效与安全性。
要点
- 现有证据级别低,尚无某种溶栓药在皮瓣挽救中显示更优效果
- 皮瓣危象的最佳管理尚无共识,需前瞻性随机研究明确适应证与剂量
核心结论
- 现有文献未能为微血管血栓患者的最佳管理提供满意且一致的证据。
- 皮瓣危象的最佳管理尚未达成共识。
研究设计与样本
- 系统综述,遵循 PRISMA 指南,检索 Medline、Embase 和 PubMed 1987 年 1 月至 2019 年 1 月的文献。
- 共筛选 105 篇文章,最终纳入 27 项研究和病例报告,由一位作者进行评审。
- 纳入标准为报告使用溶栓药物进行游离皮瓣挽救手术或方案的英文研究。
主要发现
- 其余 14 篇病例报告介绍溶栓药物用于挽救游离皮瓣的临床使用。
- 现有文献总体证据级别低,所涉及的溶栓药物均未显示更优的挽救结局。
临床怎么用
- 溶栓药物可用于游离皮瓣挽救,但药物选择与方案缺乏一致证据支持。
- 临床决策需结合个体情况,并关注适应证、剂量与给药方式等尚未明确的问题。
局限性
- 现有文献总体证据级别低。
- 缺乏前瞻性随机研究,适应证、剂量、给药方式、疗效与安全性均未确定。
- 文献筛选与数据提取由一位作者完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microvascular free tissue transfer is a reliable method for reconstructive surgery. However, pedicle thrombosis remains a serious complication following free tissue transfer as no consensus has been reached on the optimal management of failing flaps. The purpose of this systematic review is to examine the current evidence on the use of thrombolytic drugs and their effects on microvascular flap salvage rates. METHODS: A systematic literature search was performed using Medline, Embase, and, PubMed databases to identify scientific literature published between January 1987 and January 2019. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles of English language studies reporting on free flap salvage procedures or protocols using thrombolytic drugs were included and reviewed by one author. RESULTS: Of 105 articles screened, 27 studies and case reports were included and qualified for data extraction. Overall, the level of evidence of the current literature is low. Thirteen retrospective studies tried to demonstrate a systemic approach for thrombolysis in flap salvage. The other 14 case reports presented clinical use of thrombolytic drugs to salvage free flaps. None of the thrombolytic agents presented had superior salvage outcomes. CONCLUSION: A review on the current literature did not provide satisfactory and consistent evidence for the optimal management of patients with microvascular thrombosis, since no consensus has been reached on the optimal management of failing flaps. Prospective randomized studies are needed regarding their indications, dosages, and methods of administration, efficacy, and safety.
引用
- Brouwers K, Kruit AS, Hummelink S, et al. Management of free flap salvage using thrombolytic drugs: A systematic review. J Plast Reconstr Aesthet Surg. 2020. PMID: 32591263. doi:10.1016/j.bjps.2020.05.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。